Emily B Tsai, MD
Diagnostic Radiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 15 years
- Stanford University School of Medicine, 2011
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care · Washington Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tsai’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A126063 · Current
Licensed to practise in California · since 2013 · expires 2027-05-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$104,748
Medicare paid this office $104,748 for 3,995 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| X-ray of chest, 1 view | 1,960 | $35,430 | $7 |
| Ct scan of chest without contrast | 372 | $17,026 | $43 |
| X-ray of chest, 2 views | 1,085 | $11,188 | $9 |
| Ct scan of chest without contrast | 250 | $10,851 | $42 |
| Low dose ct scan of chest for lung cancer screening | 93 | $7,564 | $81 |
See all 16 services
| X-ray of chest, 1 view | 1,960 | $35,430 | $7 |
| Ct scan of chest without contrast | 372 | $17,026 | $43 |
| X-ray of chest, 2 views | 1,085 | $11,188 | $9 |
| Ct scan of chest without contrast | 250 | $10,851 | $42 |
| Low dose ct scan of chest for lung cancer screening | 93 | $7,564 | $81 |
| Ct scan of chest with contrast | 149 | $7,439 | $48 |
| Ct scan of chest with contrast | 129 | $6,320 | $46 |
| X-ray of chest, 2 views | 261 | $2,419 | $9 |
| Low dose ct scan of chest for lung cancer screening | 26 | $1,491 | $57 |
| Limited or follow-up ct scan | 27 | $1,002 | $37 |
| X-ray of abdomen, 1 view | 67 | $594 | $8 |
| Limited or follow-up ct scan | 15 | $579 | $39 |
| X-ray of pelvis, 1-2 views | 32 | $220 | $7 |
| X-ray of chest, 1 view | 25 | $195 | $7 |
| X-ray of thigh bone, minimum 2 views | 16 | $126 | $7 |
| X-ray of foot, minimum of 3 views | 14 | $108 | $7 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | – | – | 21 | 21 | – | – |
| Needle biopsy of growth of abdominal cavity | – | – | – | 13 | – | – |
| Needle biopsy of lung or chest tissue, accessed through the skin | – | 11 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
3,995 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 16% · Women 50% · Also on Medicaid 28% · Health risk score 2.31. Above the middle of the specialty; the typical diagnostic radiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Chronic kidney disease 40% · Diabetes 37% · Heart failure 36% · Atrial fibrillation 36% · Cancer 30% · COPD 25% · Depression 25% · Dementia 16% · Stroke 15%.
The office billed $1,474,898, Medicare allowed $133,548 and paid $104,748; for 7,661 services of 46 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 3,995 | 7,661 | 74 | 2.31 | $1,474,898 | $104,748 |
| 2023 | 4,119 | 8,734 | 74 | 2.21 | $1,540,274 | $124,046 |
| 2022 | 3,389 | 6,599 | 75 | 2.17 | $1,182,994 | $99,837 |
| 2021 | 2,323 | 4,366 | 74 | 2.27 | $729,310 | $66,581 |
| 2020 | 2,946 | 6,556 | 73 | 2.22 | $926,503 | $105,087 |
| 2019 | 3,563 | 7,606 | 74 | 2.26 | $1,000,010 | $135,664 |
| 2018 | 2,721 | 5,361 | 73 | 2.31 | $627,395 | $88,988 |
| 2017 | 1,379 | 2,557 | 72 | 2.08 | $361,089 | $47,892 |
| 2016 | 181 | 248 | 72 | 3.05 | $29,859 | $6,406 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| X-ray of chest, 1 view | 2,204 | $47,861 | $8 |
| Ct scan of chest without contrast | 412 | $19,367 | $45 |
| Ct scan of chest without contrast | 394 | $18,385 | $45 |
| Ct scan of chest with contrast | 166 | $8,951 | $49 |
| X-ray of chest, 2 views | 829 | $8,911 | $9 |
| Ct scan of chest with contrast | 147 | $7,396 | $48 |
| Low dose ct scan of chest for lung cancer screening | 52 | $3,076 | $59 |
| X-ray of chest, 2 views | 249 | $2,339 | $9 |
| Low dose ct scan of chest for lung cancer screening | 17 | $1,017 | $60 |
| X-ray of abdomen, 1 view | 72 | $751 | $8 |
| X-ray of knee, 4 or more views | 15 | $210 | $11 |
| X-ray of shoulder, minimum of 2 views | 16 | $146 | $9 |
| X-ray of chest, 1 view | 18 | $145 | $8 |
| X-ray of pelvis, 1-2 views | 13 | $102 | $7 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 16 | $71 | $4 |
2022: 16 services
| X-ray of chest, 1 view | 1,970 | $36,702 | $8 |
| Ct scan of chest without contrast | 310 | $14,486 | $44 |
| Ct scan of chest without contrast | 295 | $13,065 | $43 |
| Ct scan of chest with contrast | 150 | $7,537 | $49 |
| Ct scan of chest with contrast | 118 | $5,940 | $46 |
| X-ray of chest, 2 views | 526 | $5,328 | $9 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 21 | $2,886 | $137 |
| Low dose ct scan of chest for lung cancer screening | 42 | $2,494 | $59 |
| Review by radiologist of ct guidance for needle placement | 32 | $2,171 | $64 |
| Low dose ct scan of chest for lung cancer screening | 23 | $1,385 | $60 |
| X-ray of chest, 2 views | 143 | $1,306 | $9 |
| Needle biopsy of growth of abdominal cavity | 12 | $971 | $75 |
| X-ray of abdomen, 1 view | 74 | $693 | $8 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 51 | $253 | $5 |
| X-ray of pelvis, 1-2 views | 16 | $119 | $7 |
| X-ray of chest, 1 view | 13 | $97 | $7 |
2021: 13 services
| X-ray of chest, 1 view | 1,393 | $25,235 | $8 |
| Ct scan of chest without contrast | 222 | $9,901 | $42 |
| Ct scan of chest without contrast | 192 | $8,447 | $43 |
| Ct scan of chest with contrast | 96 | $4,799 | $48 |
| Ct scan of chest with contrast | 88 | $4,683 | $48 |
| X-ray of chest, 2 views | 315 | $3,163 | $9 |
| Core needle biopsy of lung or center cavity of chest (mediastinum), accessed through skin | 21 | $2,640 | $126 |
| Review by radiologist of ct guidance for needle placement | 19 | $1,264 | $67 |
| Low dose ct scan of chest for lung cancer screening | 19 | $879 | $46 |
| X-ray of chest, 2 views | 77 | $663 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $459 | $11 |
| X-ray of abdomen, 1 view | 26 | $261 | $8 |
| X-ray of pelvis, 1-2 views | 12 | $89 | $7 |
2020: 15 services
| X-ray of chest, 1 view | 1,715 | $39,268 | $9 |
| Ct scan of chest without contrast | 390 | $19,851 | $49 |
| Ct scan of chest without contrast | 279 | $14,099 | $47 |
| Ct scan of chest with contrast | 165 | $8,901 | $50 |
| Ct scan of chest with contrast | 130 | $7,383 | $51 |
| X-ray of chest, 2 views | 464 | $5,189 | $10 |
| Review by radiologist of ct guidance for needle placement | 28 | $1,934 | $69 |
| Low dose ct scan (ldct) for lung cancer screening | 21 | $1,250 | $60 |
| Needle biopsy of lung or chest tissue, accessed through the skin | 11 | $904 | $82 |
| X-ray of abdomen, 1 view | 70 | $766 | $9 |
| X-ray of chest, 2 views | 58 | $523 | $9 |
| 3d radiographic procedure with computerized image postprocessing | 14 | $522 | $37 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $170 | $11 |
| X-ray of pelvis, 1-2 views | 18 | $145 | $8 |
| X-ray of chest, 1 view | 13 | $103 | $8 |
2019: 12 services
| X-ray of chest, 1 view | 1,801 | $40,557 | $8 |
| Ct scan of chest without contrast | 546 | $30,679 | $51 |
| Ct scan of chest without contrast | 367 | $19,820 | $50 |
| Ct scan of chest with contrast | 262 | $16,017 | $51 |
| Ct scan of chest with contrast | 169 | $10,046 | $52 |
| X-ray of chest, 2 views | 810 | $8,806 | $10 |
| Low dose ct scan (ldct) for lung cancer screening | 33 | $1,926 | $58 |
| Review by radiologist of ct guidance for needle placement | 25 | $1,684 | $67 |
| X-ray of chest, 2 views | 46 | $450 | $10 |
| X-ray of abdomen, 1 view | 38 | $391 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $233 | $11 |
| X-ray of pelvis, 1-2 views | 15 | $122 | $8 |
2018: 12 services
| X-ray of chest, 1 view | 1,380 | $27,669 | $8 |
| Ct scan of chest without contrast | 310 | $15,972 | $49 |
| Ct scan of chest without contrast | 323 | $15,917 | $46 |
| Ct scan of chest with contrast | 175 | $9,898 | $51 |
| Ct scan of chest with contrast | 146 | $7,889 | $50 |
| X-ray of chest, 2 views | 569 | $5,865 | $9 |
| Low dose ct scan (ldct) for lung cancer screening | 28 | $1,605 | $57 |
| Review by radiologist of ct guidance for needle placement | 12 | $618 | $52 |
| X-ray of chest, 2 views | 58 | $580 | $10 |
| X-ray of abdomen, 1 view | 40 | $423 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $132 | $11 |
| X-ray of pelvis, 1-2 views | 13 | $96 | $7 |
2017: 9 services
| X-ray of chest, 1 view, front | 686 | $13,208 | $8 |
| Ct scan of chest without contrast | 216 | $10,066 | $45 |
| Ct scan of chest without contrast | 173 | $8,139 | $45 |
| Ct scan of chest with contrast | 110 | $6,616 | $56 |
| Ct scan of chest with contrast | 76 | $4,533 | $55 |
| X-ray of chest, 2 views, front and side | 220 | $2,198 | $10 |
| Review by radiologist of ct guidance for needle placement | 12 | $617 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $142 | $11 |
| X-ray of chest, 2 views, front and side | 12 | $118 | $10 |
2016: 4 services
| Ct scan of abdomen and pelvis with contrast | 15 | $1,016 | $68 |
| Ct scan of blood vessels of chest with contrast | 14 | $1,012 | $72 |
| X-ray of chest, 1 view, front | 103 | $891 | $8 |
| Ct scan head or brain without contrast | 21 | $697 | $33 |
Medicaid work
$45,392 in 2024
Medicaid paid $45,392 for 4,552 billed services this clinician did in 2024, up to 223 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Radiologic examination, chest; single view | 3,167 | $22,439 |
| Radiologic examination, chest; 2 views | 992 | $10,096 |
| Computed tomography, thorax, diagnostic; without contrast material | 271 | $9,507 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 85 | $3,187 |
| X-ray of abdomen, 1 view | 37 | $163 |
| 2024 | 4,552 | 5 | 223 | $45,392 |
| 2023 | 5,714 | 5 | 236 | $48,490 |
| 2022 | 3,959 | 5 | 186 | $31,065 |
| 2021 | 2,952 | 5 | 158 | $24,659 |
| 2020 | 3,539 | 5 | 158 | $31,445 |
| 2019 | 3,202 | 5 | 118 | $34,404 |
| 2018 | 2,101 | 6 | 127 | $18,386 |
See the largest Medicaid services in earlier years
2023
| Radiologic examination, chest; single view | 4,404 | $30,733 |
| Radiologic examination, chest; 2 views | 881 | $7,556 |
| Computed tomography, thorax, diagnostic; without contrast material | 304 | $6,721 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 111 | $3,388 |
| X-ray of abdomen, 1 view | 14 | $93 |
2022
| Radiologic examination, chest; single view | 3,209 | $20,220 |
| Computed tomography, thorax, diagnostic; without contrast material | 221 | $5,682 |
| Radiologic examination, chest; 2 views | 489 | $4,467 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 25 | $600 |
| X-ray of abdomen, 1 view | 15 | $97 |
2021
| Radiologic examination, chest; single view | 2,492 | $15,673 |
| Computed tomography, thorax, diagnostic; without contrast material | 138 | $3,943 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 76 | $2,831 |
| Radiologic examination, chest; 2 views | 230 | $2,123 |
| X-ray of abdomen, 1 view | 16 | $89 |
2020
| Radiologic examination, chest; single view | 2,881 | $18,630 |
| Computed tomography, thorax, diagnostic; without contrast material | 262 | $8,070 |
| Radiologic examination, chest; 2 views | 294 | $2,786 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 43 | $1,643 |
| X-ray of abdomen, 1 view | 59 | $316 |
2019
| Radiologic examination, chest; single view | 2,169 | $14,205 |
| Computed tomography, thorax, diagnostic; without contrast material | 359 | $9,772 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 176 | $6,476 |
| Radiologic examination, chest; 2 views | 470 | $3,789 |
| X-ray of abdomen, 1 view | 28 | $163 |
2018
| Radiologic examination, chest; single view | 1,448 | $8,151 |
| Computed tomography, thorax, diagnostic; without contrast material | 171 | $3,895 |
| DIAGNOSTIC COMPUTED TOMOGRAPHY THORAX W/CONTRAST | 95 | $3,630 |
| Radiologic examination, chest; 2 views | 265 | $2,040 |
| Service | 95 | $428 |
| Service | 27 | $242 |
Money from drug and device companies
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Boehringer Ingelheim International GmbH · A Phase Iia/Iib, Randomised, Double Blind, Placebo-Controlled, Parallel-Group Dose-Finding Study To Examine the Efficacy and Safety of Bi 1839100 Administered Orally Over A 12-Week Treatment Period in Patients With Idiopathic Pulmonary Fibrosis Or Progressive Pulmonary Fibrosis With Clinically Meaningful Cough · 2025 | This clinician | $3,900 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1831481647
- Licence
- CA A126063California A126063: Current · expires 2027-05-31
- Trained
- Stanford University School of Medicine, 2011 · 15 years ago
- Group
- Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Diagnostic radiology (2085R0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2011-05-11
- NPI last updated
- 2024-11-11
- NPI record certified
- 2024-11-11
This is when the NPI record was last certified, not a medical board exam.